Cargando…

Hospitalised Myocarditis and Pericarditis Cases in Germany Indicate a Higher Post-Vaccination Risk for Young People Mainly after COVID-19 Vaccination

Detalles Bibliográficos
Autores principales:	Montag, Karsten, Kampf, Günter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605208/ https://www.ncbi.nlm.nih.gov/pubmed/36294393 http://dx.doi.org/10.3390/jcm11206073

Ejemplares similares

Acute lower respiratory tract infections have mainly become a secondary diagnosis in 2022 in hospitalized COVID-19 cases in Germany
por: Montag, Karsten, et al.
Publicado: (2023)

Myocarditis and pericarditis after vaccination for COVID‐19
por: Hudson, Blake, et al.
Publicado: (2021)

Myocarditis, pericarditis with COVID-19 vaccines in the Netherlands
Publicado: (2021)

Myocarditis or pericarditis following COVID-19 vaccination
Publicado: (2021)

Myocarditis and pericarditis after COVID-19 vaccination
Publicado: (2021)

Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination
por: Pepe, Salvatore, et al.
Publicado: (2021)

Myocarditis, pericarditis included in labelling for two COVID vaccines
Publicado: (2021)

COVID-19 mRNA vaccination and myocarditis or pericarditis
por: Husby, Anders, et al.
Publicado: (2022)

Myocarditis, pericarditis, and COVID-19 mRNA-vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
por: Mahasing, Chayanit, et al.
Publicado: (2023)

Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
por: Li, Minghui, et al.
Publicado: (2021)

COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
por: Calcaterra, Giuseppe, et al.
Publicado: (2021)

PRAC updates risk of myocarditis and pericarditis with mRNA vaccines
Publicado: (2021)

Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination
por: Weintraub, Eric S., et al.
Publicado: (2022)

Development of myocarditis and pericarditis after COVID‐19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations
por: Alami, Abdallah, et al.
Publicado: (2022)

Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients
por: Hajjo, Rima, et al.
Publicado: (2021)

Response to case report on myocarditis and pericarditis after COVID‐19 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination( )
por: Chua, Gilbert T, et al.
Publicado: (2021)

The benefit of vaccination against COVID-19 outweighs the potential risk of myocarditis and pericarditis
por: Klamer, T. A., et al.
Publicado: (2022)

NZ's Medsafe reminder: pericarditis/myocarditis may occur after Comirnaty vaccination
Publicado: (2022)

Low rate of myocarditis/pericarditis after COVID-19 mRNA vaccines
Publicado: (2022)

Myocarditis or Pericarditis Following the COVID-19 Vaccination in Adolescents: A Systematic Review
por: Li, Minglong, et al.
Publicado: (2022)

COVID-19 Vaccine Induced Myocarditis and Pericarditis: A Single Centre Experience
por: Chalk, T.
Publicado: (2022)

Development of myocarditis and pericarditis after COVID‐19 vaccination: A deeper insight
por: Fatima, Maurish, et al.
Publicado: (2023)

Benefits v. risks of COVID-19 vaccination: an examination of vaccination policy impact on the occurrence of myocarditis and pericarditis
por: Carleton, Bruce C., et al.
Publicado: (2023)

Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective
por: Alami, Abdallah, et al.
Publicado: (2023)

COVID-19, Myocarditis and Pericarditis
por: Fairweather, DeLisa, et al.
Publicado: (2023)

Temporal relationship of myocarditis and pericarditis following COVID-19 vaccination: A pragmatic approach
por: Anastassopoulou, Cleo, et al.
Publicado: (2022)

mRNA COVID-19 Vaccine Related Myocarditis and Pericarditis in the Australian Capital Territory
por: O'Driscoll, R., et al.
Publicado: (2022)

Correction: Mahasing et al. Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand. Vaccines 2023, 11, 749
por: Mahasing, Chayanit, et al.
Publicado: (2023)

Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers
por: Luk, Adriana, et al.
Publicado: (2021)

Development of myocarditis and pericarditis after COVID-19 vaccination in adult population: A systematic review
por: Fatima, Maurish, et al.
Publicado: (2022)

COVID-19-Induced Myocarditis and mRNA Vaccine-Related Pericarditis: A Case Report
por: Voltarelli, Clara L, et al.
Publicado: (2022)

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines
por: Le Vu, Stéphane, et al.
Publicado: (2022)

Development of myocarditis and pericarditis after COVID‐19 vaccination in children and adolescents: A systematic review
por: Fatima, Maurish, et al.
Publicado: (2023)

Myocarditis and Pericarditis in Patients with COVID-19
por: Shah, Jassim Zaheen, et al.
Publicado: (2020)

Tozinameran: Myocarditis and pericarditis: case report
Publicado: (2022)

Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines
por: Rafaniello, Concetta, et al.
Publicado: (2022)

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study
por: Su, Wei-Ju, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_caaikqomvbcr385t8k3d6t5oja